ArticleESMO open2022

Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.

L Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.